human
bocaviru
hbov
identifi
worldwid
children
lower
respiratori
tract
infect
incid
approxim
role
hbov
pathogenesi
howev
larg
unknown
littl
known
epidemiolog
viru
studi
seroepidemiolog
hbov
infect
capsid
protein
express
insect
cell
express
put
major
capsid
protein
insect
cell
led
format
viruslik
particl
exhibit
typic
icosahedr
appear
parvovirus
diamet
approxim
nm
express
particl
use
establish
enzymelink
immunosorb
assay
elisa
method
serum
sampl
group
children
variou
age
china
test
igg
antibodi
hbov
hbov
antibodi
detect
high
healthi
children
year
children
hospit
lower
respiratori
tract
infect
seroposit
age
group
children
show
significantli
higher
level
hbov
igg
antibodi
healthi
counterpart
divid
age
cohort
result
show
healthi
children
seroconvert
age
thu
hbov
appear
common
infect
children
potenti
pathogenesi
viru
especi
role
lower
respiratori
tract
infect
children
warrant
investig
human
bocaviru
hbov
member
genu
bocaviru
subfamili
parvovirina
cotmor
tattersal
bocavirus
far
identifi
includ
bovin
parvoviru
type
bpv
chen
et
al
canin
minut
viru
cnmv
schwartz
et
al
recent
identifi
human
bocaviru
hbov
alland
et
al
bpv
caus
diarrhea
mild
respiratori
symptom
calv
inocul
intranas
via
et
al
cnmv
associ
fetal
infect
lead
reproduct
failur
neonat
respiratori
diseas
parrish
hbov
first
clone
detect
suggest
hbov
less
common
respiratori
syncyti
viru
probabl
also
rhinovirus
infant
respiratori
ill
howev
viru
approxim
common
influenza
virus
human
metapneumoviru
parainfluenza
viru
adenovirus
probabl
common
coronavirus
parainfluenza
virus
mcintosh
exact
role
hbov
pathogenesi
lower
respiratori
tract
infect
unknown
requir
studi
time
neither
viru
isol
infecti
clone
report
serolog
studi
hbov
infect
japan
shown
overal
seropreval
rate
protein
hbov
use
immunofluoresc
assay
popul
age
month
year
endo
et
al
current
detect
human
bocaviru
children
lower
respiratori
tract
infect
reli
dna
amplif
pcr
howev
pcr
assay
reflect
cours
hbov
infect
therefor
method
detect
hbov
infect
larg
scale
requir
diagnos
character
role
hbov
human
diseas
purifi
hbov
protein
need
develop
accur
effici
enzymelink
immunosorb
assay
elisa
help
character
potenti
hbov
etiolog
lower
respiratori
tract
infect
segment
hbov
genom
sequenc
alland
et
al
segment
lack
left
righthand
palindrom
hairpin
termini
therefor
plasmid
contain
sequenc
hbov
infecti
genom
organ
hbov
close
resembl
bpv
alland
et
al
qiu
et
al
two
major
orf
encod
nonstructur
protein
least
twocapsid
protein
respect
recombin
protein
express
insect
cell
use
success
detect
specif
antibodi
hbov
infect
immunofluoresc
assay
endo
et
al
studi
major
capsid
gene
hbov
express
insect
cell
express
insect
cell
led
format
viruslik
particl
vlp
typic
icosahedr
appear
parvovirus
diamet
approxim
nm
purifi
vlp
use
establish
elisa
detect
igg
antibodi
hbov
human
sera
group
children
variou
age
china
result
show
hbov
infect
appear
common
children
hbov
gene
nt
stockholm
isol
alland
et
al
synthes
use
overlap
pcr
strategi
base
publish
sequenc
genbank
access
nc
synthet
gene
confirm
sequenc
insert
baculoviru
express
transfer
vector
invitrogen
without
ha
tag
gener
recombin
baculovirus
bachbovcap
bachbovcapha
follow
accord
commerci
avail
kit
bactobac
invitrogen
sdspage
immunoblot
analysi
essenti
done
previous
describ
qiu
et
al
cell
infect
multipl
infect
moi
harvest
day
later
low
speed
centrifug
remov
supernat
cell
resuspend
mm
nahco
solut
cellsml
left
ice
min
result
cell
lyse
vlp
recov
suspens
debri
remov
centrifug
supernat
ad
satur
nh
final
concentr
pellet
collect
lowspe
centrifug
vlpcontain
solut
adjust
densiti
gml
ad
solid
cscl
spun
rpm
sorval
least
h
c
fraction
ml
taken
bottom
refract
index
measur
use
abb
refractomet
fraction
contain
approxim
densiti
gml
expect
empti
parvoviru
capsid
dialyz
pb
neg
stain
perform
use
modif
standard
twostep
drop
method
ie
adsorpt
follow
neg
stain
final
vlp
prepar
stain
aqueou
uranyl
acet
ph
hayat
imag
resolv
jeol
transmiss
electron
microscop
electron
microscop
core
facil
univers
missouricolumbia
vlp
form
hbov
capsid
protein
employ
establish
elisa
detect
igg
antibodi
react
hbov
briefli
purifi
vlp
coat
onto
plate
coat
buffer
mm
nahco
ph
buffer
neutral
pb
ph
buffer
coat
concentr
vlp
determin
variou
concentr
gml
gml
gml
gml
gml
gml
coat
plate
wash
three
time
pbst
tween
pb
block
ad
l
nonfat
milk
pbst
c
min
serum
sampl
ad
duplic
dilut
serial
dilut
pbst
min
reaction
c
follow
three
wash
pbst
goat
antihuman
igg
hrp
conjug
sigma
dilut
pbst
ad
min
c
follow
ad
substrat
ophenylendiamin
dihydrochlorid
sigma
st
loui
mo
absorb
serum
od
nm
read
mean
valu
duplic
calcul
total
antibodi
detect
influenza
viru
b
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
perform
use
complementfix
test
autom
seramat
system
manufactur
diagnosi
kit
diess
monteriggioni
itali
titer
greater
detect
seramat
system
consid
posit
nasopharyng
aspir
sampl
hbov
genom
detect
collect
simultan
realtim
quantit
pcr
perform
previous
describ
lin
et
al
two
hundr
microlitr
nasopharyng
aspir
sampl
use
extract
dna
blood
dneasi
kit
qiagen
valencia
ca
hemagglutin
assay
perform
ubottom
plate
becton
dickinson
franklin
lake
nj
briefli
human
type
red
blood
cell
centrifug
rpm
min
red
blood
cell
wash
twice
resuspend
alsev
buffer
mm
sodium
citrat
mm
nacl
mm
sucros
ph
final
concentr
serial
twofold
dilut
bpv
gift
dr
f
brent
johnson
johnson
et
al
hbov
vlp
prepar
alsev
buffer
volum
l
l
red
blood
cell
ad
well
mix
plate
incub
c
overnight
hemagglutin
titer
express
minimum
viru
concentr
requir
hemagglutin
red
blood
cell
suspens
complet
januari
decemb
serum
nasopharyng
aspir
sampl
collect
children
clinic
diagnosi
lower
respiratori
tract
infect
day
hospit
wenl
hospit
wenzhou
medic
colleg
zhejiang
provinc
china
standard
clinic
diagnosi
lower
respiratori
tract
infect
made
xray
chest
examin
presenc
typic
acut
respiratori
tract
infect
symptom
includ
cough
dyspnea
wheez
hypoxia
total
control
serum
sampl
collect
healthi
children
determin
standard
physic
examin
wenl
hospit
wenzhou
medic
colleg
zhejiang
provinc
china
nasopharyng
aspir
sampl
serum
sampl
taken
inform
consent
obtain
parent
legal
guardian
twenti
serum
sampl
healthi
us
blood
donor
age
purchas
certifi
neg
hbv
hcv
hiv
htlvi
ii
innov
research
inc
southfield
mi
put
orf
major
capsid
protein
hbov
nt
stockholm
isol
alland
et
al
synthes
use
overlap
pcr
strategi
insert
baculoviru
express
transfer
vector
invitrogen
without
ha
tag
ypydvpdya
gener
recombin
baculovirus
perform
accord
protocol
bactobac
kit
invitrogen
final
four
recombin
baculovirus
gener
cell
infect
thirdpassag
stock
virus
moi
day
later
cell
lysat
prepar
subject
sdspage
immunoblot
analysi
result
show
express
reach
approxim
total
cellular
protein
fig
lane
ident
band
molecular
weight
approxim
kda
confirm
immunoblot
probe
antiha
antibodi
fig
lane
ha
tag
use
seed
followup
prepar
vlp
final
vlp
prep
analyz
standard
neg
stain
electron
microscop
foulongn
et
al
typic
icosahedr
appear
parvovirus
diamet
approxim
nm
uniformli
seen
fig
indic
hbov
protein
form
parvoviruslik
particl
isol
natur
circul
human
bocaviru
success
yet
human
parvoviru
bovin
bocaviru
bpv
vlp
form
express
capsid
protein
virus
capabl
hemagglutin
human
red
blood
cell
brown
cohen
brown
et
al
johnson
hoggan
johnson
et
al
surprisingli
shown
fig
vlp
hbov
hemagglutin
human
red
blood
cell
even
high
concentr
mgml
wherea
purifi
bpv
mgml
hemagglutin
titer
high
result
hemagglutin
assay
suggest
hbov
may
like
human
adenoassoci
viru
type
walter
et
al
hemagglutin
human
red
blood
cell
walter
et
al
hbov
detect
hemagglutin
assay
repres
difficulti
detect
isol
viru
clinic
specimen
adult
often
expos
mani
respiratori
virus
well
human
parvovirus
anderson
et
al
aav
chirmul
et
al
peden
et
al
serum
sampl
blood
donor
unit
state
innov
re
inc
southfield
mi
use
test
reactiv
hbov
vlp
first
optim
concentr
coat
vlp
assay
concentr
gml
mm
nahco
ph
determin
develop
od
valu
approxim
nm
two
strong
reactiv
serum
serum
dilut
pb
fig
serum
also
confirm
strongli
reactiv
protein
immunoblot
fig
lane
fig
hemagglutin
assay
purifi
bpv
mgml
hbov
vlp
mgml
twofold
dilut
alsev
buffer
red
cell
human
type
ad
incub
c
overnight
purifi
bpv
abl
hemagglutin
human
red
cell
dilut
howev
hbov
vlp
show
hemagglutin
activ
b
next
elisa
perform
serial
dilut
sera
select
healthi
blood
donor
test
produc
typic
elisa
curv
end
point
od
valu
dilut
neg
sera
posit
sera
fig
presum
neg
serum
also
confirm
immunoblot
fig
lane
sinc
strongli
reactiv
presum
neg
sera
gave
discriminatori
result
dilut
dilut
chosen
analyz
subsequ
serum
sampl
next
serum
sampl
blood
donor
test
two
differ
coat
condit
mm
nahco
ph
vs
pb
ph
signific
differ
condit
detect
sampl
test
tabl
higher
ph
buffer
mm
nahco
ph
may
abl
disassembl
vlp
wang
et
al
thu
antigen
epitop
may
expos
reason
order
inclus
possibl
chose
high
ph
buffer
mm
nahco
ph
use
largescal
analysi
determin
specif
assay
purifi
bovin
bocaviru
bpv
gift
dr
f
brent
johnson
johnson
et
al
coat
concentr
gml
test
sera
show
low
od
valu
indic
igg
antibodi
posit
sera
specif
hbov
antigen
tabl
defin
cutoff
valu
posit
neg
pn
ratio
calcul
p
od
read
hbovvlp
antigen
n
od
read
control
bpv
antigen
mean
n
sera
healthi
blood
donor
therefor
cutoff
valu
equal
pn
valu
use
data
analysi
thu
serum
sampl
od
put
consid
igg
posit
hbov
studi
assay
appli
remain
adult
serum
sampl
determin
sera
healthi
adult
us
blood
donor
age
year
posit
hbov
igg
cutoff
high
titer
eg
serum
titer
fig
serum
sampl
use
detect
hbov
igg
antibodi
taken
children
hospit
lower
respiratori
tract
infect
previous
screen
use
autom
complementfix
test
antibodi
neg
influenza
viru
b
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
hbov
igg
antibodi
sera
detect
elisa
use
vlp
coat
buffer
contain
mm
nahco
od
valu
sera
categor
group
base
age
month
month
month
month
year
older
year
sera
children
lower
respiratori
tract
infect
fig
month
month
month
year
year
sera
healthi
children
fig
group
level
hbov
igg
antibodi
detect
reactiv
vlp
express
od
valu
nm
increas
age
increas
similar
seropreval
human
first
human
parvoviru
identifi
caus
diseas
anderson
et
al
brown
et
al
group
healthi
children
year
age
nearli
half
appar
previous
infect
viru
level
igg
antibodi
high
group
fig
therefor
hbov
infect
children
clearli
occur
frequent
viru
specif
antibodi
last
longer
virus
patient
acut
viral
infect
signific
differ
od
valu
observ
sera
healthi
children
compar
sera
children
lower
respiratori
tract
infect
similar
age
group
p
fig
compar
symbol
cutoff
line
b
suggest
hbov
infect
occur
frequent
children
lower
respiratori
tract
infect
children
lower
respiratori
tract
infect
younger
year
age
sampl
found
strongli
posit
od
serum
sampl
test
healthi
children
age
group
od
valu
five
serum
sampl
healthi
children
age
od
sampl
children
older
year
age
variou
antigen
hbov
vlp
bpv
bsa
control
coat
plate
high
ph
buffer
ph
neutral
ph
buffer
ph
hbov
vlp
eight
serum
sampl
healthi
blood
donor
incub
dilut
specif
igg
detect
od
valu
nm
sampl
shown
number
bold
show
strong
posit
reactiv
coat
antigen
interestingli
nasopharyng
aspir
sampl
collect
children
lower
respiratori
tract
infect
found
hbov
genom
posit
quantit
pcr
rang
genom
copi
ml
five
sampl
three
genom
copi
ml
strongli
serum
igg
posit
od
valu
respect
two
mildli
posit
od
tabl
result
suggest
acut
recent
infect
hbov
patient
studi
hbov
vlp
purifi
cell
express
put
hbov
capsid
protein
employ
success
elisa
detect
igg
antibodi
human
serum
sampl
elisa
show
specif
hbov
protein
crossreact
observ
close
relat
bovin
bocaviru
bpv
capsid
first
report
demonstr
hbov
protein
capabl
form
vlp
second
show
presenc
hbov
specif
igg
antibodi
human
sera
importantli
significantli
higher
level
hbov
igg
antibodi
rel
age
group
children
acut
respiratori
infect
found
compar
children
without
acut
respiratori
infect
suggest
hbov
may
agent
caus
play
role
acut
respiratori
infect
children
nevertheless
character
presenc
igm
antibodi
igg
doubl
serum
sampl
requir
subsequ
studi
precis
evalu
statu
infect
hbov
acut
respiratori
infect
addit
high
posit
rate
hbov
igg
antibodi
sera
healthi
us
blood
donor
age
year
observ
studi
indic
hbov
infect
widespread
us
togeth
result
also
indic
hbov
like
first
encount
childhood
consist
previou
suggest
alland
et
al
arnold
et
al
bastien
et
al
choi
et
al
foulongn
et
al
lin
et
al
et
al
qu
et
al
sloot
et
al
weissbrich
et
al
empti
vlp
use
effect
antigen
elisa
evalu
antibodi
soderlund
et
al
capsid
form
hbov
protein
appear
characterist
icosahedr
parvovir
particl
use
antigen
detect
igg
hbov
studi
differ
coat
buffer
compar
initi
optim
elisa
signific
differ
reactiv
serum
sampl
observ
high
ph
ph
use
standard
coat
buffer
hbov
vlp
might
denatur
high
ph
buffer
system
wang
et
al
human
igg
antibodi
studi
result
conform
antigen
capsid
denatur
protein
show
signific
differ
vs
manaresi
et
al
human
metapneumoviru
hmpv
anoth
newli
identifi
respiratori
viru
detect
patient
either
upper
lower
respiratori
tract
diseas
van
den
hoogen
et
al
seroepidemiolog
studi
hmpv
reveal
nearli
children
month
age
antibodi
hmpv
virtual
children
becom
seroposit
age
ebihara
et
al
van
den
hoogen
et
al
similar
singl
studi
far
report
relat
seropreval
hbov
infect
done
japanes
popul
use
immunofluoresc
assay
posit
rate
lowest
age
group
month
gradual
increas
age
year
group
year
group
year
group
year
group
endo
et
al
studi
rel
lower
hbov
iggposit
rate
approxim
observ
healthi
children
younger
month
rate
increas
approxim
healthi
children
older
year
age
rel
lower
posit
rate
studi
compar
japanes
group
could
explain
immuofluoresc
assay
use
japanes
group
also
detect
hbov
specif
igm
test
sera
endo
et
al
children
clinic
diagnos
lower
respiratori
tract
infect
studi
present
hbov
igg
seropreval
rate
follow
children
younger
month
age
children
year
age
children
year
age
howev
high
level
igg
observ
posit
sera
children
lower
respiratori
tract
infect
od
valu
higher
either
reinfect
acut
infect
hbov
may
occur
hbov
may
caus
agent
lower
respiratori
tract
infect
children
nasopharyng
aspir
sampl
children
show
signific
level
hbov
genom
gcml
interestingli
five
children
hospit
lower
respiratori
tract
infect
signific
igg
antibodi
titer
od
three
high
igg
antibodi
titer
od
suggest
acut
infect
hbov
hbov
coinfect
respiratori
virus
alland
et
al
fri
et
al
found
mani
case
therefor
role
hbov
lower
respiratori
tract
infect
unclear
studi
design
initi
probe
independ
pathogenesi
hbov
lower
respiratori
tract
infect
high
level
igg
od
valu
higher
posit
sera
children
lower
respiratori
tract
infect
suggest
certainli
prove
hbov
may
caus
infect
independ
although
igg
antibodi
present
singl
serum
sampl
reflect
acut
infect
high
rate
igg
posit
sera
healthi
children
suggest
hbov
infect
common
children
genom
detect
shown
previous
alland
et
al
arnold
et
al
bastien
et
al
choi
et
al
foulongn
et
al
lin
et
al
et
al
qu
et
al
sloot
et
al
weissbrich
et
al
infect
occur
children
high
incid
asymptomat
specif
igg
antibodi
appear
sever
day
igm
persist
year
seroposit
igg
shown
reach
healthi
european
blood
donor
gallinella
et
al
thu
infect
hbov
might
also
occur
wide
high
seropreval
healthi
children
adult
suggest
hbov
infect
requir
medic
attent
children
conclus
studi
show
first
time
express
hbov
protein
insect
cell
form
parvovir
like
particl
reassembl
icosahedr
structur
nm
parvovir
like
particl
hemagglutin
human
type
red
blood
cell
unlik
bovin
bocaviru
bpv
elisa
base
vlp
establish
detect
igg
antibodi
hbov
sera
signific
differ
serum
reactiv
hbov
vlp
observ
high
percentag
higher
od
valu
present
sera
children
hospit
lower
respiratori
tract
infect
compar
sera
healthi
children
therefor
vlpsbase
elisa
appropri
earli
diagnosi
hbov
infect
studi
viru
infect
children
lower
respiratori
tract
infect
addit
hbov
vlp
potenti
use
futur
vaccin
develop
